All treatments
Treatment
ABX464, The placebo for the 25 and 50 mg ABX464 hard capsules., ABX464 clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomized, double-blind, placebo-controlled, multicenter phase III study to evaluate the efficacy and safety of ABX464 once daily for induction treatment in subjects with moderately to severely active ulcerative colitis
This study is testing a new medicine, ABX464, for people aged 18 and over with moderate to severe ulcerative colitis. It aims to see if the medicine helps improve symptoms and gut healing more than a dummy medicine (placebo), and if it's safe to use.
For: Moderately to severely active ulcerative colitisFrance · Spain · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomized, double-blind, placebo-controlled, multicenter phase III study to evaluate the efficacy and safety of ABX464 once daily for induction treatment in subjects with moderately to severely active ulcerative colitis
This study is testing a new medicine, ABX464, for people with moderate to severe ulcerative colitis. Researchers want to see if it helps improve the gut lining and reduces symptoms after 8 weeks, and if it's safe to use.
For: Moderately to severely active ulcerative colitisFrance · Spain · Italy